598
Male volunteers ( n=12) participated in a randomised, two-period, crossover trial evaluating the effect of multiple doses of 600 mg rifampicin once daily for 7 days on repaglinide metabolism.
 Male volunteers ( n=12): Subject; Male: Subject.Gender; n=12: Subject.Population; repaglinide metabolism: Effect; multiple doses of 600 mg rifampicin once daily for 7 days: Treatment; multiple doses of 600 mg: Treatment.Dosage; rifampicin: Treatment.Drug; once daily: Treatment.Freq; 7 days: Treatment.Duration
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Male volunteers ( n=12): Subject; Male: Subject.Gender; n=12: Subject.Population; repaglinide metabolism: Effect; multiple doses of 600 mg rifampicin once daily for 7 days: Treatment; multiple doses of 600 mg: Treatment.Dosage; rifampicin: Treatment.Drug; once daily: Treatment.Freq; 7 days: Treatment.Duration